Physician profile
Harold Pretorius
NPI 1760431159
$158,899.74
in general payments reported to CMS, 2019-2025
100 companies · $4,615 in 2025
The $4,615 reported for 2025 was more than what 91% of Nuclear Medicine providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $37K · 2021: $23K · 2022: $8,068 · 2023: $11K · 2024: $26K · 2025: $4,615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Education: $107 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,900.00 |
| Food and Beverage | $14,706.28 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,800.00 |
| Education | $106.94 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $35,549.51 | 2019-2024 | Farxiga |
| Amarin Pharma, INC. | $28,824.44 | 2019-2023 | |
| Mannkind Corporation | $20,352.13 | 2019-2025 | Afrezza |
| Corcept Therapeutics | $16,824.39 | 2019-2025 | Korlym |
| Clarus Therapeutics INC. | $14,503.29 | 2020-2021 | |
| Abbvie INC. | $12,898.79 | 2019-2025 | |
| Genetesis, INC. | $4,000.00 | 2021 | |
| Ibsa Pharma INC. | $3,501.06 | 2019-2024 | Tirosint, Tirosint, Licart |
| Lilly USA, LLC | $1,947.23 | 2019-2025 | Kisunla, Mounjaro, Jardiance |
| Novo Nordisk INC | $1,818.08 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $1,117.87 | 2019-2025 | Repatha, Repatha, Tepezza |
| Sanofi-Aventis U.S. LLC | $1,095.25 | 2019-2025 | |
| Pfizer INC. | $1,081.30 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $1,012.61 | 2020-2025 | Recorlev, Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $932.55 | 2022-2025 |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $863.77 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Allergan, INC. | $628.29 | 2019-2021 | |
| Antares Pharma, INC. | $610.42 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Beta Bionics, INC. | $591.64 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $569.87 | 2019-2024 | Trulance, Cycloset, Xifaxan |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $474.52 | 2022-2024 | Caplyta |
| Radius Health, INC. | $452.82 | 2019-2023 | Tymlos |
| Madrigal Pharmaceuticals | $439.85 | 2024-2025 | Rezdiffra, Resmetirom |
| Medtronic, INC. | $429.66 | 2021-2025 | Minimed 780g, Minimed 770g |
| Dexcom, INC. | $406.74 | 2019-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $405.65 | 2019-2025 | |
| Tandem Diabetes Care, INC. | $358.96 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Merck Sharp & Dohme LLC | $318.44 | 2019-2023 | Steglatro, Steglujan |
| Janssen Pharmaceuticals, INC | $306.63 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $306.13 | 2019-2025 | Contrave, Onzetra Xsail, Nexletol |
| Alexion Pharmaceuticals, INC. | $301.90 | 2021-2024 | Strensiq |
| Insulet Corporation | $241.10 | 2019-2025 | Omnipod |
| Opko Pharmaceuticals, LLC | $228.02 | 2019-2025 | Rayaldee |
| Cequr Corporation | $224.51 | 2023-2025 | Cequr Simplicity |
| Horizon Therapeutics Plc | $221.57 | 2020-2023 | Tepezza |
| Biohaven Pharmaceuticals, INC. | $210.30 | 2021 | |
| Biogen, INC. | $203.38 | 2021-2025 | Leqembi |
| Teva Pharmaceuticals USA, INC. | $199.27 | 2019-2020 | |
| Recordati_rare_diseases_inc. | $192.93 | 2021-2025 | Isturisa |
| Aimmune Therapeutics, INC. | $191.36 | 2024-2025 | Zenpep |
| Eisai INC. | $188.49 | 2025 | |
| Esperion Therapeutics, INC. | $185.13 | 2020-2025 | Nexletol |
| Neurocrine Biosciences, INC. | $167.02 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $159.84 | 2019-2023 | Trintellix |
| Biohaven Pharmaceutical Holding Company Ltd. | $149.09 | 2022 | |
| Atricure, INC. | $138.99 | 2024 | |
| Avvisto Therapeutics, LLC | $134.36 | 2024-2025 | Cycloset |
| Abbott Laboratories | $133.34 | 2024 | Freestyle Libre 3 |
| Amneal Pharmaceuticals LLC | $130.39 | 2019-2025 | Unithroid |
| Idorsia Pharmaceuticals US INC | $127.91 | 2023 | Quviviq |
| Ucb, INC. | $125.00 | 2023 | Nayzilam |
| Endo Pharmaceuticals INC. | $123.97 | 2019-2021 | |
| Corium, LLC | $118.19 | 2022-2023 | Adlarity |
| Regeneron Pharmaceuticals, INC. | $114.37 | 2019 | |
| Amryt Pharma Holdings Ltd | $101.61 | 2022-2023 | Mycapssa |
| Medtronic Minimed, INC. | $100.78 | 2019 | |
| Progenics Pharmaceuticals, INC. | $100.00 | 2023 | Pylarify |
| Chiasma, INC. | $94.99 | 2021 | |
| Vivus LLC | $89.66 | 2019-2024 | Pancreaze |
| Ascensia Diabetes Care US INC. | $87.64 | 2023-2024 | |
| Nestle Healthcare Nutrition INC. | $85.81 | 2021-2023 | |
| Kowa Pharmaceuticals America, INC. | $82.55 | 2019-2022 | |
| Kyowa Kirin, INC. | $78.80 | 2023-2025 | Crysvita |
| Acerus Pharmaceuticals Corporation | $72.49 | 2020-2022 | |
| Verity Pharmaceuticals INC. | $72.33 | 2024-2025 | Tlando |
| Ironwood Pharmaceuticals, INC | $68.22 | 2020-2021 | |
| Halozyme INC | $66.23 | 2023 | |
| Acadia Pharmaceuticals INC | $66.07 | 2022-2023 | Nuplazid |
| Otsuka America Pharmaceutical, INC. | $61.39 | 2024 | Rexulti |
| Zealand Pharma US, INC. | $60.85 | 2020-2021 | |
| Tolmar, INC. | $60.71 | 2023-2025 | Jatenzo |
| Axsome Therapeutics, INC. | $60.13 | 2025 | Auvelity |
| Alnylam Pharmaceuticals INC. | $52.06 | 2020-2024 | Oxlumo, Givlaari |
| Sequel Med Tech, LLC | $48.86 | 2025 | Twiist |
| Avanir Pharmaceuticals, INC. | $44.33 | 2019-2020 | |
| Circassia INC. | $40.36 | 2019 | |
| Evoke Pharma, INC. | $37.68 | 2022-2023 | Gimoti |
| Ascendis Pharma Endocrinology INC | $37.62 | 2024-2025 | Yorvipath |
| Lundbeck LLC | $34.43 | 2023 | Rexulti |
| Ultragenyx Pharmaceutical INC. | $28.08 | 2019-2021 | |
| Mdd US Operations, LLC | $27.76 | 2022 | |
| Ionis Pharmaceuticals, INC. | $24.15 | 2025 | Tryngolza |
| Averitas Pharma INC. | $22.48 | 2025 | Qutenza |
| Boehringer Ingelheim International Gmbh | $21.83 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $20.99 | 2024 | |
| Blue Earth Diagnostics | $20.20 | 2022 | |
| Covis Pharma Gmbh | $19.55 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $18.43 | 2022 | |
| Valeritas, INC. | $17.46 | 2019 | |
| Chiesi USA, INC. | $17.05 | 2024 | Mycapssa |
| Gilead Sciences, INC. | $14.25 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.50 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $13.31 | 2019 | |
| Amphastar Pharmaceuticals, INC. | $13.30 | 2024 | |
| Grt US Holding, INC. | $13.19 | 2021 | |
| Therapeuticsmd, INC. | $12.63 | 2019 | |
| Promius Pharma LLC | $11.57 | 2019 | |
| Lifescan, INC. | $11.04 | 2019 | |
| Supernus Pharmaceuticals, INC. | $10.92 | 2019 | Xyosted |
| Medicure Pharma INC. | $10.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Pretorius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.